These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26457223)

  • 1. Comparison of Immunohistochemical Expression of Antiapoptotic Protein Survivin in Normal Oral Mucosa, Oral Leukoplakia, and Oral Squamous Cell Carcinoma.
    Negi A; Puri A; Gupta R; Nangia R; Sachdeva A; Mittal M
    Patholog Res Int; 2015; 2015():840739. PubMed ID: 26457223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and Expression of Survivin in Potentially Malignant Lesions and Squamous Cell Carcinoma: A Comparative Study.
    Sakthivel R; Ramamoorthy A; Jeddy N; Singaram M
    Cureus; 2020 Apr; 12(4):e7551. PubMed ID: 32382455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-alpha overexpression in proliferative verrucous leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
    Kannan R; Bijur GN; Mallery SR; Beck FM; Sabourin CL; Jewell SD; Schuller DE; Stoner GD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jul; 82(1):69-74. PubMed ID: 8843456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Mucin 4 in leukoplakia and oral squamous cell carcinoma: An immunohistochemical study.
    Narashiman S; Narasimhan M; Venkatraman G
    J Oral Maxillofac Pathol; 2014 Jan; 18(1):25-31. PubMed ID: 24959033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of budding uninhibited by benzimidazole related 1 in leukoplakia and oral squamous cell carcinoma.
    Sravya T; Sivaranjani Y; Rao GV
    J Oral Maxillofac Pathol; 2016; 20(1):71-7. PubMed ID: 27194865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
    Sudha VM; Hemavathy S
    Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of survivin, caspase-3 in oral precancerous lesions and oral squamous-cell carcinoma].
    Ding YP; Li SX; Wu HR; Zhang XY; Tang XF; Sun Z
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Feb; 45(2):85-8. PubMed ID: 20368001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of survivin and its correlation to angiogenesis in oral squamous cell carcinoma].
    Liu YM; Huang JH; Feng DY; Guo XC
    Ai Zheng; 2005 Nov; 24(11):1354-7. PubMed ID: 16552962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Implication of Survivin Expression in Oral Squamous Cell Carcinoma-An Immunohistochemical Study.
    Ajithkumar M; Murali CR; Vani NV
    J Contemp Dent Pract; 2019 May; 20(5):577-581. PubMed ID: 31316021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical analysis of the p53 tumor suppressor gene product in oral leukoplakia].
    Kikegawa A
    Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):51-9. PubMed ID: 11321806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the expression of GLUT-1 in oral leukoplakia.
    Doss DM; Nirmal M; Veeravarmal ; Saravanan R; Venkatesh A
    J Oral Maxillofac Pathol; 2020; 24(2):308-314. PubMed ID: 33456240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Evaluation of Cancer Stem Cells in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia Using NANOG: An Immunohistochemical Study.
    I A; Raghavan Pillai VB; P Joseph A; Ramani P; P J; Ramalingam K
    Cureus; 2024 Feb; 16(2):e55111. PubMed ID: 38558704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human MutL homolog 1 immunoexpression in oral leukoplakia and oral squamous cell carcinoma: A prospective study in Indian population.
    Chaudhari NT; Tupkari JV; Joy T; Ahire MS
    J Oral Maxillofac Pathol; 2016; 20(3):453-461. PubMed ID: 27721611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of survivin in oral epithelial dysplasia and different grades of oral squamous cell carcinoma.
    Ghritlahare H; Einstein A; Singaraju S; Patel S; Gulati N; Mishra SD
    J Oral Maxillofac Pathol; 2022; 26(4):451-457. PubMed ID: 37082058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and its relationship of murine double minute 2 and P53 protein in oral leukoplakia and squamous cell carcinoma].
    Han BF; Wu PF; Pan J; Li Y; Li LJ
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Feb; 29(1):79-82. PubMed ID: 21427907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical evaluation of survivin in oral lichen planus and oral squamous cell carcinoma - a retrospective study.
    Lingam HT; Swetha P; Manyam R
    Med Pharm Rep; 2021 Jul; 94(3):341-347. PubMed ID: 34430856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of survivin mRNA in healthy oral mucosa, oral leucoplakia and oral cancer.
    Lodi G; Franchini R; Bez C; Sardella A; Moneghini L; Pellegrini C; Bosari S; Manfredi M; Vescovi P; Carrassi A
    Oral Dis; 2010 Jan; 16(1):61-7. PubMed ID: 19732355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podoplanin expression in oral potentially malignant disorders and oral squamous cell carcinoma.
    A G D; Janardanan-Nair B; B R V
    J Clin Exp Dent; 2017 Dec; 9(12):e1418-e1424. PubMed ID: 29410757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.